These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 17629667)
1. Survival prediction of patients with advanced cancer: the predictive accuracy of the model based on biological markers. Kikuchi N; Ohmori K; Kuriyama S; Shimada A; Nakaho T; Yamamuro M; Tsuji I J Pain Symptom Manage; 2007 Dec; 34(6):600-6. PubMed ID: 17629667 [TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction. Martin L; Watanabe S; Fainsinger R; Lau F; Ghosh S; Quan H; Atkins M; Fassbender K; Downing GM; Baracos V J Clin Oncol; 2010 Oct; 28(28):4376-83. PubMed ID: 20805456 [TBL] [Abstract][Full Text] [Related]
3. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. Gripp S; Moeller S; Bölke E; Schmitt G; Matuschek C; Asgari S; Asgharzadeh F; Roth S; Budach W; Franz M; Willers R J Clin Oncol; 2007 Aug; 25(22):3313-20. PubMed ID: 17664480 [TBL] [Abstract][Full Text] [Related]
4. Preoperative predictors for residual tumor after surgery in patients with ovarian carcinoma. de Jong D; Eijkemans MJ; Lie Fong S; Gerestein CG; Kooi GS; Baalbergen A; van der Burg ME; Burger CW; Ansink AC Oncology; 2007; 72(5-6):293-301. PubMed ID: 18198490 [TBL] [Abstract][Full Text] [Related]
5. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model. Sun QF; Ding JG; Xu DZ; Chen YP; Hong L; Ye ZY; Zheng MH; Fu RQ; Wu JG; Du QW; Chen W; Wang XF; Sheng JF J Viral Hepat; 2009 Jul; 16(7):464-70. PubMed ID: 19413694 [TBL] [Abstract][Full Text] [Related]
6. Predicting risk of breast cancer in postmenopausal women by hormone receptor status. Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA; J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216 [TBL] [Abstract][Full Text] [Related]
7. Recursive partitioning analysis of prognostic factors for survival in patients with advanced cancer. Chow E; Abdolell M; Panzarella T; Harris K; Bezjak A; Warde P; Tannock I Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1169-76. PubMed ID: 18938045 [TBL] [Abstract][Full Text] [Related]
8. Validation of a predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. Chow E; Abdolell M; Panzarella T; Harris K; Bezjak A; Warde P; Tannock I Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):280-7. PubMed ID: 18676092 [TBL] [Abstract][Full Text] [Related]
9. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis. Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of symptoms of hospitalised advanced cancer patients. Teunissen SC; de Graeff A; de Haes HC; Voest EE Eur J Cancer; 2006 Oct; 42(15):2510-6. PubMed ID: 16962316 [TBL] [Abstract][Full Text] [Related]
11. Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scale. Chuang RB; Hu WY; Chiu TY; Chen CY J Pain Symptom Manage; 2004 Aug; 28(2):115-22. PubMed ID: 15276192 [TBL] [Abstract][Full Text] [Related]
12. Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study. Suh SY; Ahn HY Eur J Cancer; 2007 Apr; 43(6):1051-9. PubMed ID: 17349786 [TBL] [Abstract][Full Text] [Related]
13. Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy. Dehing-Oberije C; Yu S; De Ruysscher D; Meersschout S; Van Beek K; Lievens Y; Van Meerbeeck J; De Neve W; Rao B; van der Weide H; Lambin P Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):355-62. PubMed ID: 19095367 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism. Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656 [TBL] [Abstract][Full Text] [Related]
15. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems. Huo TI; Hsia CY; Huang YH; Lin HC; Lee PC; Lui WY; Chiang JH; Chiou YY; Loong CC; Lee SD J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404 [TBL] [Abstract][Full Text] [Related]
16. Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometry. Veltri RW; Miller MC; Isharwal S; Marlow C; Makarov DV; Partin AW Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):102-10. PubMed ID: 18199716 [TBL] [Abstract][Full Text] [Related]
17. Base deficit-based predictive modeling of outcome in trauma patients admitted to intensive care units in Dutch trauma centers. Kroezen F; Bijlsma TS; Liem MS; Meeuwis JD; Leenen LP J Trauma; 2007 Oct; 63(4):908-13. PubMed ID: 18090025 [TBL] [Abstract][Full Text] [Related]
18. The acute physiology and chronic health evaluation III outcome prediction in patients admitted to the intensive care unit after pneumonectomy. Keegan MT; Harrison BA; Brown DR; Whalen FX; Cassivi SD; Afessa B J Cardiothorac Vasc Anesth; 2007 Dec; 21(6):832-7. PubMed ID: 18068061 [TBL] [Abstract][Full Text] [Related]
19. Prediction of Lynch syndrome in consecutive patients with colorectal cancer. Green RC; Parfrey PS; Woods MO; Younghusband HB J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167 [TBL] [Abstract][Full Text] [Related]
20. [Serum lactate dehydrogenase and CD4+/CD8+ lymphocyte ratio predict survival in terminally ill cancer patients]. Ohara T; Takahashi M; Yamanaka H; Yamamoto Y; Shimada A; Nakaho T Gan To Kagaku Ryoho; 2002 Oct; 29(10):1779-83. PubMed ID: 12402429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]